More patients in rural areas across the nation could soon have increased access to vision-saving eye screenings based on a new multi-center clinical trial, led by an investigator at the University of Wisconsin Department …
Amy Pikalek
DOVS Support Staff, Local Artist Team Up to Spread Kindness
Members of the UW Department of Ophthalmology and Visual Sciences support staff and a local artist recently teamed up to share a simple, but important reminder: Kindness is everything. During the support staff’s monthly meeting …
Global Ophthalmology Updates – January 2022
Residents Take Part in Global Simulation Wet Lab On Saturday, January 8, our three senior residents joined UW ophthalmologist Jennifer Larson, MD, for a global surgical simulation wet lab training at the VA Hospital in …
Remembering Dr. Clare Hutson
The UW Department of Ophthalmology and Visual Sciences is saddened to announce the passing of our friend and longtime colleague, Clare F. Hutson, MD, on January 10, 2022. He was 95 years old. A Badger …
Meet the Newest DOVS Faculty Member: Shaoqin (Sarah) Gong
The UW Department of Ophthalmology and Visual Sciences is pleased to welcome Shaoqin (Sarah) Gong, PhD, as our newest faculty member. Gong comes to DOVS with more than 20 years of experience as a scientist, …
DOVS and UW School of Veterinary Medicine Team Up for Ocular Pathology Day
The UW Department of Ophthalmology and Visual Sciences (DOVS) and the UW School of Veterinary Medicine were proud to have successfully hosted another annual Ocular Pathology Day on September 17, 2021. The morning began virtually …
CLN-0500
A Randomized, Parallel-Arm, Active Control, Multicenter Study Assessing the Safety and Efficacy of Dextenza for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
ATMOSPHERE
A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD (ATMOSPHERE)
UNITY
A Phase 2a, Prospective, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Safety, Tolerability and Evidence of Activity of a Single Intravitreal Injection of UBX1325 in Patients with Diabetic Macular Edema